American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy
Open accessThe DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
Abstract
Mechanism of Action of Coumarin Anticoagulant DrugsWarfarin, a coumarin derivative, produces an anticoagulant effect by interfering with the cyclic interconversion of vitamin K and its 2,3 epoxide (vitamin K epoxide).Vitamin K is a cofactor for the carboxylation of glutamate residues to ␥-carboxyglutamates (Gla) on the N-terminal regions of vitamin K-dependent proteins (Figure 1).[1][2][3][4][5][6] These proteins, which include the coagulation factors II, VII, IX, and X, require ␥-carboxylation by vitamin K for biological activity.By inhibiting the vitamin K conversion cycle, warfarin induces hepatic production of partially decarboxylated proteins with reduced coagulant activity.7,8 Carboxylation promotes binding of the vitamin K-dependent coagulation factors to phospholipid surfaces, thereby accelerating blood coagulation.9 -11 ␥-Carboxylation requires the reduced form of vitamin K (vitamin KH 2 ).Coumarins block the formation of vitamin KH 2 by inhibiting the enzyme vitamin K epoxide reductase, thereby limiting the ␥-carboxylation of the vitamin K-dependent coagulant proteins.In addition, the vitamin K antagonists inhibit carboxylation of the regulatory anticoagulant proteins C and S. The anticoagulant effect of coumarins can be overcome by low doses of vitamin K 1 (phytonadione) because vitamin K 1 bypasses vitamin K epoxide reductase (Figure 1).Patients treated with large doses of vitamin K 1 (usually Ͼ5 mg) can become resistant to warfarin for up to a week because vitamin K 1 accumulating in the liver is available to bypass vitamin K epoxide reductase.Warfarin also interferes with the carboxylation of Gla proteins synthesized in bone.[12][13][14][15] Although these effects contribute to fetal bone abnormalities when mothers are treated with warfarin during pregnancy, 16,17 there is no evidence that warfarin directly affects bone metabolism when administered to children or adults.The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel.Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130036007 · Cited by 2,071
Petersen, P., Godtfredsen, J., Boysen, G., Andersen, E., & Andersen, B. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91200-2 · Cited by 1,820
EAFT (European Atrial Fibrillation Trial) Study Group (1993) · The Lancet · doi:10.1016/0140-6736(93)92358-z · Cited by 1,741
Stroke Prevention in Atrial Fibrillation Study. Final results.
(1991) · Circulation · doi:10.1161/01.cir.84.2.527 · Cited by 1,696
(1990) · New England Journal of Medicine · doi:10.1056/nejm199011293232201 · Cited by 1,530
Mas, J.-L., Arquizan, C., Lamy, C., Zuber, M., Cabanes, L., Derumeaux, G., & Coste, J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011503 · Cited by 1,361
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary
Fuster, V., Rydén, L. E., Asinger, R. W., Cannom, D. S., Crijns, H. J., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01587-x · Cited by 1,348
Self-citationOsteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone
Hauschka, P. V., Lian, J. B., Cole, D. E., & Gundberg, C. M. (1989) · Physiological Reviews · doi:10.1152/physrev.1989.69.3.990 · Cited by 1,272
Aithal, G. P., Day, C. P., Kesteven, P. J., & Daly, A. K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)04474-2 · Cited by 1,243
A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke
Mohr, J. P., Thompson, J. L. P., Lazar, R. M., Levin, B., Sacco, R. L., Furie, K. L., Kistler, J. P., Albers, G. W., Pettigrew, L. C., Adams, H. P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011258 · Cited by 1,168
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
Ezekowitz, M. D., Bridgers, S. L., James, K. E., Carliner, N. H., Colling, C. L., Gornick, C. C., Krause-Steinrauf, H., Kurtzke, J. F., Nazarian, S. M., Radford, M. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211123272002 · Cited by 1,160
Hemorrhagic Complications of Anticoagulant Treatment
Levine, M. N., Raskob, G., Landefeld, S., & Kearon, C. (2001) · Chest · doi:10.1378/chest.119.1_suppl.108s · Cited by 1,134
ACC/AHA guidelines for the management of patients with valvular heart disease
Bonow, R., Carabello, B., de Leon, A., Edmunds, L. H., Fedderly, B., Freed, M., Gaasch, W., McKay, C., Nishimura, R., O’Gara, P., et al. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00454-9 · Cited by 1,134
Weitz, J. I., Hudoba, M., Massel, D., Maraganore, J., & Hirsh, J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114723 · Cited by 1,123
Self-citationCanadian atrial fibrillation anticoaguiation (CAFA) study
Connolly, S. J., Laupacis, A., Gent, M., Roberts, R. S., Cairns, J. A., & Joyner, C. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90585-w · Cited by 1,111
Kearon, C., Gent, M., Hirsh, J., Weitz, J., Kovacs, M. J., Anderson, D. R., Turpie, A. G., Green, D., Ginsberg, J. S., Wells, P., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903253401201 · Cited by 1,072
Self-citationWarfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
(1993) · New England Journal of Medicine · doi:10.1056/nejm199301143280227 · Cited by 1,067
Higashi, M. K. (2002) · JAMA · doi:10.1001/jama.287.13.1690 · Cited by 1,048
Maternal and fetal sequelae of anticoagulation during pregnancy
Hall, J. G., Pauli, R. M., & Wilson, K. M. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90181-3 · Cited by 997
(1997) · New England Journal of Medicine · doi:10.1056/nejm199701163360301 · Cited by 970
The natural history of idiopathic dilated cardiomyopathy
Fuster, V., Gersh, B. J., Giuliani, E. R., Tajik, A. J., Brandenburg, R. O., & Frye, R. L. (1981) · The American Journal of Cardiology · doi:10.1016/0002-9149(81)90534-8 · Cited by 943
Self-citationSchulman, S., Rhedin, A.-S., Lindmarker, P., Carlsson, A., Lärfars, G., Nicol, P., Loogna, E., Svensson, E., Ljungberg, B., Walter, H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506223322501 · Cited by 932
Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin
Hylek, E. M., & Singer, D. E. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-11-199406010-00001 · Cited by 919
Optimal Oral Anticoagulant Therapy in Patients with Mechanical Heart Valves
Cannegieter, S. C., Rosendaal, F. R., Wintzen, A. R., van der Meer, F. J. M., Vandenbroucke, J. P., & Briet, E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507063330103 · Cited by 908
Roth, G. J., & Majerus, P. W. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108132 · Cited by 861
Cytochrome P4502C9: an enzyme of major importance in human drug metabolism
Miners, J. O., & Birkett, D. J. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00721.x · Cited by 844
Management of Anticoagulation before and after Elective Surgery
Kearon, C., & Hirsh, J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705223362107 · Cited by 812
Self-citationVongpatanasin, W., Hillis, L. D., & Lange, R. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608083350607 · Cited by 811
Hylek, E. M., Skates, S. J., Sheehan, M. A., & Singer, D. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608223350802 · Cited by 789
Bern, M. M., Lokich, J. J., Wallach, S. R., Bothe, A., Benotti, P. N., Arkin, C. F., Greco, F. A., Huberman, M., & Moore, C. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-3-112-6-423 · Cited by 788
Landefeld, C. S., & Goldman, L. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90564-0 · Cited by 778
Beyth, R. J., Quinn, L. M., & Landefeld, C. S. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00198-3 · Cited by 773
Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis
Hull, R., Hirsh, J., Jay, R., Carter, C., England, C., Gent, M., Turpie, A. G. G., McLoughlin, D., Dodd, P., Thomas, M., et al. (1982) · New England Journal of Medicine · doi:10.1056/nejm198212303072704 · Cited by 728
Self-citationLow-molecular-weight heparin during instability in coronary artery disease
Fragmin during Instability in Coronary Artery Disease (FRISC) study group (1996) · The Lancet · doi:10.1016/s0140-6736(96)91270-2 · Cited by 685
PREVENTION OF VENOUS THROMBOSIS AND PULMONARY EMBOLISM IN INJURED PATIENTS
Sevitt, S., & Gallagher, N. G. (1959) · The Lancet · doi:10.1016/s0140-6736(59)91464-3 · Cited by 651
The Effect of Warfarin on Mortality and Reinfarction after Myocardial Infarction
Smith, P., Arnesen, H., & Holme, I. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007193230302 · Cited by 638
Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis
Hull, R., Delmore, T., Genton, E., Hirsh, J., Gent, M., Sackett, D., McLoughlin, D., & Armstrong, P. (1979) · New England Journal of Medicine · doi:10.1056/nejm197910183011602 · Cited by 604
Self-citationThe Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism
Schulman, S., Granqvist, S., Holmström, M., Carlsson, A., Lindmarker, P., Nicol, P., Eklund, S.-G., Nordlander, S., Lärfars, G., Leijd, B., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702063360601 · Cited by 604
Managing Oral Anticoagulant Therapy
Ansell, J., Hirsh, J., Dalen, J., Bussey, H., Anderson, D., Poller, L., Jacobson, A., Deykin, D., & Matchar, D. (2001) · Chest · doi:10.1378/chest.119.1_suppl.22s · Cited by 572
Self-citationNEED FOR LONG-TERM ANTICOAGULANT TREATMENT IN SYMPTOMATIC CALF-VEIN THROMBOSIS
LAGERSTEDT, C. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90459-3 · Cited by 569
O'Neill, D. D., Westerman, D. P., & Sacco, W. (1966) · doi:10.21236/ad0635168 · Cited by 566
Oates, J. A., Wood, A. J. J., & Hirsh, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106273242606 · Cited by 563
Self-citationA Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve Replacement
Turpie, A., Gent, M., Laupacis, A., Latour, Y., Gunstensen, J., Basile, F., Klimek, M., & Hirsh, J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308193290802 · Cited by 547
Self-citation(1997) · ACC Current Journal Review · doi:10.1016/s1062-1458(97)83303-x · Cited by 539
Interactions of Warfarin with Drugs and Food
Wells, P. S., Holbrook, A. M., Crowther, N. R., & Hirsh, J. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-9-199411010-00009 · Cited by 536
Self-citationThe Mode of Action of Vitamin K
Nelsestuen, G. L., Zytkovicz, T. H., & Howard, J. B. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)42259-x · Cited by 528
Levine, M., Hirsh, J., Arnold, A., Gent, M., Levine, M., Arnold, A., Bramwell, V., Pritchard, K. I., Stewart, D., Warr, D., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90008-6 · Cited by 510
Self-citationSchulman, S., Svenungsson, E., & Granqvist, S. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00060-6 · Cited by 497
Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves
Stein, P. D., Alpert, J. S., Bussey, H. I., Dalen, J. E., & Turpie, A. G. G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.220s · Cited by 496
(1997) · Annals of Neurology · doi:10.1002/ana.410420606 · Cited by 480
Reactivation of Unstable Angina after the Discontinuation of Heparin
Théroux, P., Waters, D., Lam, J., Juneau, M., & McCans, J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207163270301 · Cited by 464
Adjusted Subcutaneous Heparin versus Warfarin Sodium in the Long-Term Treatment of Venous Thrombosis
Hull, R., Delmore, T., Carter, C., Hirsh, J., Genton, E., Gent, M., Turpie, G., & McLaughlin, D. (1982) · New England Journal of Medicine · doi:10.1056/nejm198201283060401 · Cited by 436
Self-citationMechanism of coumarin action: significance of vitamin K epoxide reductase inhibition
Whitlon, D. S., Sadowski, J. A., & Suttie, J. W. (1978) · Biochemistry · doi:10.1021/bi00601a003 · Cited by 384
Cohen, M., Adams, P. C., Parry, G., Xiong, J., Chamberlain, D., Wieczorek, I., Fox, K. A., Chesebro, J. H., Strain, J., & Keller, C. (1994) · Circulation · doi:10.1161/01.cir.89.1.81 · Cited by 378
Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation
Hylek, E. M. (1998) · JAMA · doi:10.1001/jama.279.9.657 · Cited by 378
Trial of Different Intensities of Anticoagulation in Patients with Prosthetic Heart Valves
Saour, J. N., Sieck, J. O., Mamo, L. A. R., & Gallus, A. S. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002153220703 · Cited by 368
Comparison of 5-mg and 10-mg Loading Doses in Initiation of Warfarin Therapy
Harrison, L., Johnston, M., Massicotte, M. P., Crowther, M., Moffat, K., & Hirsh, J. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-2-199701150-00006 · Cited by 359
Self-citationLow-Molecular-Weight Heparin (Fragmin) During Instability in Coronary Artery Disease (FRISC)
Swahn, E., & Wallentin, L. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00486-4 · Cited by 354
Sawicki, P. T. (1999) · JAMA · doi:10.1001/jama.281.2.145 · Cited by 351
Turpie, A. G. G., Hirsh, J., Gunstensen, J., Nelson, H., & Gent, M. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92070-3 · Cited by 315
Self-citationOral Anticoagulant Therapy in Patients With Coronary Artery Disease: A Meta-analysis
Anand, S. S. (1999) · JAMA · doi:10.1001/jama.282.21.2058 · Cited by 311
Outcome of pregnancy in women with valve prostheses.
Sbarouni, E., & Oakley, C. M. (1994) · Heart · doi:10.1136/hrt.71.2.196 · Cited by 305
Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction
(1997) · The Lancet · doi:10.1016/s0140-6736(97)01180-x · Cited by 301
Gulløv, A. L., Koefoed, B. G., Petersen, P., Pedersen, T. S., Andersen, E. D., Godtfredsen, J., & Boysen, G. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.14.1513 · Cited by 301
Calibration of Reference Thromboplastins and Standardisation of the Prothrombin Time Ratio
Kirkwood, T. B. L. (1983) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657371 · Cited by 300
Chesebro, J. H., Fuster, V., Elveback, L. R., McGoon, D. C., Pluth, J. R., Puga, F. J., Wallace, R. B., Danielson, G. K., Orszulak, T. A., Piehler, J. M., et al. (1983) · The American Journal of Cardiology · doi:10.1016/0002-9149(83)90673-2 · Cited by 300
Self-citationCromheecke, M. E., Levi, M., Colly, L. P., de Mol, B. J., Prins, M. H., Hutten, B. A., Mak, R., Keyzers, K. C., & Büller, H. R. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02470-3 · Cited by 293
Temporary Discontinuation of Warfarin Therapy: Changes in the International Normalized Ratio
White, R. H., McKittrick, T., Hutchinson, R., & Twitchell, J. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-1-199501010-00006 · Cited by 280
Atrial Fibrillation and Thromboembolism: A Decade of Progress in Stroke Prevention
Hart, R. G., & Halperin, J. L. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-9-199911020-00010 · Cited by 269
Self-citationAntithrombotic agents in coronary artery disease
Resnekov, L., Chediak, J., Hirsh, J., & Lewis, H. D. (1989) · Chest · doi:10.1378/chest.95.2.52s · Cited by 263
Self-citationPharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man
Breckenridge, A., Orme, M., Wesseling, H., Lewis, R. J., & Gibbons, R. (1974) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1974154424 · Cited by 261
Francis, C. W. (1983) · JAMA · doi:10.1001/jama.1983.03330270038029 · Cited by 256
Aging and the Anticoagulant Response to Warfarin Therapy
Gurwitz, J. H., Avorn, J., Ross-Degnan, D., Choodnovskiy, I., & Ansell, J. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-11-901 · Cited by 231
Self-citationHellemons, B. S. P., Langenberg, M., Lodder, J., Vermeer, F., Schouten, H. J. A., Lemmens, T., van Ree, J. W., & Knottnerus, J. A. (1999) · BMJ · doi:10.1136/bmj.319.7215.958 · Cited by 226
Fiore, L. D., Ezekowitz, M. D., Brophy, M. T., Lu, D., Sacco, J., & Peduzzi, P. (2002) · Circulation · doi:10.1161/hc0502.103329 · Cited by 224
Contrast sonography for detection of vesicoureteral reflux
Kaneko, K., Kuwatsuru, R., Fukuda, Y., Yamataka, A., Yabuta, K., Katayama, H., & Miyano, T. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92123-7 · Cited by 222
Multicentre randomised study of computerised anticoagulant dosage
Poller, L., Shiach, C., MacCallum, P., Johansen, A., Münster, A., Magalhäes, A., & Jespersen, J. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04147-6 · Cited by 222
Monitoring Warfarin Therapy in Patients with Lupus Anticoagulants
Moll, S., & Ortel, T. L. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-3-199708010-00001 · Cited by 214
Powers, P. J. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390040013003 · Cited by 214
Studies on the optical enantiomorphs of warfarin in man
Reilly, R. A. O. (1974) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1974162348 · Cited by 213
Landefeld, C. S., Rosenblatt, M. W., & Goldman, L. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90565-2 · Cited by 211
The Stereoselective Interaction of Warfarin and Metronidazole in Man
O'Reilly, R. A. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608122950702 · Cited by 209
ANTICOAGULANTS IN ACUTE MYOCARDIAL INFARCTION
Hilden, T., Raaschou, F., Iversen, K., & Schwartz, M. (1961) · The Lancet · doi:10.1016/s0140-6736(61)90629-8 · Cited by 206
Congenital malformations associated with the administration of oral anticoagulants during pregnancy
Lietman, P. S., Pettifor, J. M., & Benson, R. (1975) · The Journal of Pediatrics · doi:10.1016/s0022-3476(75)80986-3 · Cited by 204
Stroke in patients with heart failure and reduced left ventricular ejection fraction
Pullicino, P. M., Halperin, J. L., & Thompson, J. L. P. (2000) · Neurology · doi:10.1212/wnl.54.2.288 · Cited by 202
Self-citationAssessment of Short-term Anticoagulant Administration after Cardiac Infarction
(1969) · BMJ · doi:10.1136/bmj.1.5640.335 · Cited by 200
Protein C and the Development of Skin Necrosis During Anticoagulant Therapy
Broekmans, A. W., Bertina, R. M., Loeliger, E. A., Hofmann, V, & Klingemann, H.-G. (1983) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657378 · Cited by 199
Role of Vitamin-K-Dependent Proteins in Bone Metabolism
Price, P. A. (1988) · Annual Review of Nutrition · doi:10.1146/annurev.nu.08.070188.003025 · Cited by 196
Guidelines for prevention of thromboembolic events in valvular heart disease
Gohlke-Bärwolf, C., Acar, J., Oakley, C., Butchart, E., Burckhardt, D., Bodnar, E., Hall, R., Delahaye, J.-P., Horstkotte, D., Krémer, R., et al. (1995) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060739 · Cited by 186
Anticoagulants in Acute Myocardial Infarction: Results of a Cooperative Clinical Trial
(1973) · JAMA · doi:10.1001/jama.1973.03220340034009 · Cited by 183
Drug Interactions with Coumarin Anticoagulants
Koch-Weser, J., & Sellers, E. M. (1971) · New England Journal of Medicine · doi:10.1056/nejm197109022851005 · Cited by 180
How we diagnose and treat deep vein thrombosis
Hirsh, J., & Lee, A. Y. Y. (2002) · Blood · doi:10.1182/blood.v99.9.3102 · Cited by 179
Self-citationDrapkin, A. (1972) · JAMA · doi:10.1001/jama.222.5.541 · Cited by 178
Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial
Crowther, M. A., Julian, J., McCarty, D., Douketis, J., Kovacs, M., Biagoni, L., Schnurr, T., McGinnis, J., Gent, M., Hirsh, J., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03125-1 · Cited by 177
Self-citationLong-term Patient Self-management of Oral Anticoagulation
Ansell, J. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.20.2185 · Cited by 176
Self-citationFactors affecting the maintenance dose of warfarin.
James, A. H., Britt, R. P., Raskino, C. L., & Thompson, S. G. (1992) · Journal of Clinical Pathology · doi:10.1136/jcp.45.8.704 · Cited by 176
Poller, L., McKernan, A., Thomson, J. M., Elstein, M., Hirsch, P. J., & Jones, J. B. (1987) · BMJ · doi:10.1136/bmj.295.6609.1309 · Cited by 168
IMPROVED PRIMARY RENAL ALLOGRAFT SURVIVAL ON CYCLOSPORIN LIMITED TO WOMEN WITH PREVIOUS PREGNANCIES
HUISMAN, R. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91003-9 · Cited by 159
Anticoagulants in acute myocardial infarction. Results of a cooperative clinical trial
Ebert, R. V. (1973) · JAMA · doi:10.1001/jama.225.7.724 · Cited by 159
Low Molecular Weight Heparin After Mechanical Heart Valve Replacement
Montalescot, G., Polle, V., Collet, J., Leprince, P. N., Bellanger, A., Gandjbakhch, I., & Thomas, D. (2000) · Circulation · doi:10.1161/01.cir.101.10.1083 · Cited by 158
Mok, C. K., Boey, J., Wang, R., Chan, T. K., Cheung, K. L., Lee, P. K., Chow, J., Ng, R. P., & Tse, T. F. (1985) · Circulation · doi:10.1161/01.cir.72.5.1059 · Cited by 156
Effect of 3.2%vs3.8% Sodium Citrate Concentration on Routine Coagulation Testing
Adcock, D. M., Kressin, D. C., & Marlar, R. A. (1997) · American Journal of Clinical Pathology · doi:10.1093/ajcp/107.1.105 · Cited by 155
PREVENTION OF VENOUS THROMBOSIS AND PULMONARY EMBOLISM IN INJURED PATIENTS
Sevitt, S. (1962) · The Lancet · doi:10.1016/s0140-6736(62)92460-1 · Cited by 149
Is warfarin sodium contraindicated in the lactating mother?
McKenna, R., Cole, E. R., & Vasan, U. (1983) · The Journal of Pediatrics · doi:10.1016/s0022-3476(83)80378-3 · Cited by 145
Vitamin K deficiency from dietary vitamin K restriction in humans
Suttie, J., Mummah-Schendel, L. L., Shah, D. V., Lyle, B., & Greger, J. (1988) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/47.3.475 · Cited by 144
The warfarin-sulfinpyrazone interaction: stereochemical considerations
Toon, S., Low, L. K., Gibaldi, M., Trager, W. F., O’Reilly, R. A., Motley, C. H., & Goulart, D. A. (1986) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1986.3 · Cited by 144
Maillard, C., Berruyer, M., Serre, C., DECHAVANNE, M., & Delmas, P. D. (1992) · Endocrinology · doi:10.1210/endo.130.3.1531628 · Cited by 139
Flier, J. S., Underhill, L. H., Wessler, S., & Gitel, S. N. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409063111007 · Cited by 138
O’Reilly, R. A., Aggeler, P. M., Hoag, M. S., Leong, L. S., & Kropatkin, M. (1964) · New England Journal of Medicine · doi:10.1056/nejm196410152711602 · Cited by 135
The kinetics of activation of normal and gamma-carboxyglutamic acid-deficient prothrombins.
Malhotra, O. P., Nesheim, M. E., & Mann, K. G. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89728-9 · Cited by 130
Prospective comparative study of computer programs used for management of warfarin.
Poller, L., Wright, D., & Rowlands, M. (1993) · Journal of Clinical Pathology · doi:10.1136/jcp.46.4.299 · Cited by 118
Anand, S. S., Yusuf, S., Pogue, J. M., Weitz, J. I., & Flather, M. D. (1998) · Circulation · doi:10.1161/01.cir.98.11.1064 · Cited by 112
Management of Barrett's oesophagus
Kelley, D. J., & Shah, J. P. (1996) · The Lancet · doi:10.1016/s0140-6736(05)64794-0 · Cited by 110
Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans
O’Reilly, R. A., Trager, W. F., Rettie, A. E., & Goulart, D. A. (1987) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1987.149 · Cited by 108
O’Reilly, R. A. (1980) · New England Journal of Medicine · doi:10.1056/nejm198001033020106 · Cited by 108
A Review of Enzyme Induction of Warfarin Metabolism with Recommendations for Patient Management
Cropp, J. S., & Bussey, H. I. (1997) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1997.tb03782.x · Cited by 108
Antithrombotic Therapy for Cerebrovascular Disorders
Sherman, D. G., Dyken, M. L., Fisher, M., Gent, M., Harrison, M. J., & Hart, R. G. (1992) · CHEST Journal · doi:10.1378/chest.102.4_supplement.529s · Cited by 107
A mutation in the propeptide of Factor IX leads to warfarin sensitivity by a novel mechanism.
Chu, K. C., Wu, S. M., Stanley, T. E., Stafford, D. W., & High, K. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118956 · Cited by 106
Stroke prevention in nonvalvular atrial fibrillation: A review of prospective randomized trials
Albers, G. W., Sherman, D. G., Gress, D. R., Paulseth, J. E., & Petersen, P. (1991) · Annals of Neurology · doi:10.1002/ana.410300402 · Cited by 101
Oldenburg, J., Quenzel, E., Harbrecht, U., Fregin, A., Kreß, W., Müller, C. R., Hertfelder, H.-J., Schwaab, R., Brackmann, H., & Hanfland, P. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.2213036.x · Cited by 96
Accuracy of Laboratory and Portable Monitor International Normalized Ratio Determinations
Kaatz, S. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.17.1861 · Cited by 92
Plasma disposition of vitamin K1 in relation to anticoagulant poisoning.
Park, B. K., Scott, A., Wilson, A., Haynes, B., & Breckenridge, A. (1984) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1984.tb02526.x · Cited by 85
Accuracy and Precision of a Portable Anticoagulation Monitor in a Clinical Setting
McCurdy, S. A. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.3.589 · Cited by 81
Deep venous thrombosis and lupus anticoagulant. A case-control study.
Simioni, P., Prandoni, P., Zanon, E., Saracino, M. A., Scudeller, A., Villalta, S., Scarano, L., Girolami, B., Benedetti, L., & Girolami, A. (1996) · PubMed · Cited by 80
Resistance to Warfarin Due to Unrecognized Vitamin K Supplementation
O’Reilly, R. A., & Rytand, D. A. (1980) · New England Journal of Medicine · doi:10.1056/nejm198007173030317 · Cited by 80
Antithrombotic Therapy for Cerebrovascular Disorders
Sherman, D. G., Dyken, M. L., Gent, M., Harrison, M. J., Hart, R. G., & Mohr, J. P. (1995) · CHEST Journal · doi:10.1378/chest.108.4_supplement.444s · Cited by 79
Stroke Prevention in Nonvalvular Atrial Fibrillation
Albers, G. W., Atwood, J. E., Hirsh, J., Sherman, D. G., Hughes, R. A., & Connolly, S. J. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-9-727 · Cited by 78
Self-citationWarfarin Resistance Caused by Broccoli
Kempin, S. J. (1983) · New England Journal of Medicine · doi:10.1056/nejm198305193082016 · Cited by 78
The Optimal Duration of Anticoagulant Therapy for Venous Thrombosis
Hirsh, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506223322510 · Cited by 76
Self-citationAntithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves
Stein, P. D., Alpert, J. S., Dalen, J. E., et al. (1998) · CHEST Journal · doi:10.1378/chest.114.5_supplement.602s · Cited by 76
Anticardiolipin Antibodies and Recurrent Thromboembolism
Rance, A., Emmerich, J., & Fiessinger, J. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1655939 · Cited by 73
Fairweather, R. B., Ansell, J., van den Besselaar, A. M. H. P., Brandt, J. T., Bussey, H. I., Poller, L., Triplett, D. A., & White, R. H. R. (1998) · PubMed · Cited by 72
Self-citationKMok, C., JBoey, RWang, KChan, T., LCheung, K., Klee, P., JChow, PNg, R., & FTse, T. (1985) · Circulation · Cited by 68
Deep Venous Thrombosis and Lupus Anticoagulant
Simioni, P., Prandoni, P., Zanon, E., Saracino, M. A., Scudeller, A., Villalta, S., Scarano, L., Girolami, B., Benedetti, L., & Girolami, A. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650551 · Cited by 66
Prophylaxis of thromboembolism in pregnancy: an alternative
Lao, T. T. H., de Swiet, M., Letsky, E. A., & Walters, B. N. J. (1985) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1985.tb01082.x · Cited by 62
Drug Interactions Update: Drugs, Herbs, and Oral Anticoagulation
Wittkowsky, A. K. (2001) · Journal of Thrombosis and Thrombolysis · doi:10.1023/a:1012742628628 · Cited by 61
Is the Dose of Warfarin Prescribed by American Physicians Unnecessarily High?
Hirsh, J. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370040151026 · Cited by 60
Self-citationD’Angelo, A., Seveso, M. P., D’Angelo, S. V., Gilardoni, F., Macagni, A., Manotti, C., & Bonini, P. A. (1989) · American Journal of Clinical Pathology · doi:10.1093/ajcp/92.3.321 · Cited by 60
Anticoagulant treatment in unstable angina
Williams, D. O., Kirby, M. G., McPherson, K., et al. (1986) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1986.tb07927.x · Cited by 60
Ageno, W., & Turpie, A. G. G. (1998) · Thrombosis Research · doi:10.1016/s0049-3848(98)00092-9 · Cited by 59
Effect of Sodium Dextrothyroxine in Patients Receiving Anticoagulants
Owens, J. C., Neely, W. B., & Owen, W. R. (1962) · New England Journal of Medicine · doi:10.1056/nejm196201112660205 · Cited by 59
Warfarin Metabolism and Drug-Drug Interactions
O’Reilly, R. A. (1987) · Springer eBooks · doi:10.1007/978-1-4757-5985-3_18 · Cited by 57
INTERACTION OF IBUPROFEN AND WARFARIN ON PRIMARY HAEMOSTASIS
Schulman, S., & Henriksson, K. G. (1989) · Rheumatology · doi:10.1093/rheumatology/28.1.46 · Cited by 54
Jennings, I., Luddington, R. J., & Baglin, T. P. (1991) · Journal of Clinical Pathology · doi:10.1136/jcp.44.11.950 · Cited by 53
Effect of erythromycin in patients receiving long-term warfarin therapy.
Weibert, R. T., Lorentz, S., Townsend, R. J., Cook, C. E., Klauber, M. R., & Jagger, P. I. (1989) · PubMed · Cited by 52
Outpatient Management of Warfarin Therapy
White, R. H. R., & Mungall, D. R. (1991) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199101000-00006 · Cited by 50
Valle, P. D., Crippa, L., Safa, O., Tomassini, L., Pattarini, E., Vigano’D’Angelo, S., Sabbadini, M. G., & D’Angelo, A. (1996) · PubMed · Cited by 46
Genetic control of anticoagulation
Mannucci, P. M. (1999) · The Lancet · doi:10.1016/s0140-6736(98)00326-2 · Cited by 46
Lack of Effect of Fortified Wine Ingested During Fasting and Anticoagulant Therapy
O’Reilly, R. A. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.141.4.458 · Cited by 42
HEREDITARY RESISTANCE TO COUMARIN ANTICOAGULANT DRUGS IN MAN AND RAT*
O’Reilly, R. A., Pool, J. G., & Aggeler, P. M. (1968) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1968.tb11950.x · Cited by 39
Thrombosis in the Antiphospholipid-Antibody Syndrome
Violi, F., Ferro, D., & Valesini, G. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509073331016 · Cited by 37
Studies on the Interaction of Warfarin and Clofibrate in Man
O’Reilly, R. A., Sahud, M. A., & ROBINSON, A. J. (1972) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649370 · Cited by 37
Poller, L., MacCallum, P. K., THOMSON, J. M., & Kerns, W. (1990) · Heart · doi:10.1136/hrt.63.4.231 · Cited by 31
Oral anticoagulation in patients surviving myocardial infarction. A new approach to old data
Loeliger, E. A., & Leizorovicz, A. (1984) · European Journal of Clinical Pharmacology · doi:10.1007/bf00546723 · Cited by 29
Mungall, D. R., & White, R. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-10-878 · Cited by 29
Oral anticoagulant in patients surviving myocardial infarction
Leizorovicz, A., & Boissel, J. P. (1983) · European Journal of Clinical Pharmacology · doi:10.1007/bf00610050 · Cited by 28
Anticoagulation and atrial fibrillation
Diener, C. (2010) · Schweizer Archiv für Neurologie und Psychiatrie · doi:10.4414/sanp.2010.02182 · Cited by 27
CYP11B2 Expression in Rat Liver and the Effect of Spironolactone on Hepatic Fibrogenesis
Yang, X.-S., Li, X., Wu, P., Meng, Y., Li, S., & Lai, W. (2000) · Hormone Research in Paediatrics · doi:10.1159/000053185 · Cited by 25
Potentiation of warfarin anticoagulation by topical testosterone ointment.
Sm, L., & Weibert, R. T. (1985) · PubMed · Cited by 15
Atrial Fibrillation and Thromboembolism
Hanson, E. W., & Lowson, S. M. (1998) · Anesthesia & Analgesia · doi:10.1097/00000539-199807000-00044 · Cited by 15
Oral Anticoagulant Therapy in Patients with Coronary Artery Disease
Hackam, D. G., Anand, S. S., & Yusuf, S. (2003) · Seminars in Vascular Medicine · doi:10.1055/s-2003-44468 · Cited by 15
Meade, T. (2013) · doi:10.1186/isrctn63594484 · Cited by 15
Laboratory Monitoring of Oral Anticoagulant Therapy
Poller, L., & Samama, M. M. (1994) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30358-5 · Cited by 12
Cited by
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176857 · Cited by 8,495
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O'Gara, P. T., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.007 · Cited by 2,257
Systematic overview of warfarin and its drug and food interactions
Holbrook, A. M. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.10.1095 · Cited by 1,160
2006 WRITING COMMITTEE MEMBERS, Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.190748 · Cited by 1,114
Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin
Gage, B., Eby, C., Johnson, J., Deych, E., Rieder, M., Ridker, P., Milligan, P., Grice, G., Lenzini, P., Rettie, A., et al. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.10 · Cited by 847
Metadata
- Authors
- Hirsh, J., Fuster, V., Ansell, J., & Halperin, J. L.
- Venue
- Circulation
- Published
- 2003-04
- Volume
- 107
- Issue
- 12
- Pages
- 1692-1711
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2027151097
- Cited by
- 911
- References
- 165
- FWCI
- 24.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.